Interestingly, CD154+ AfuLy-reactive cells of COVID-19 patients showed stronger Ki-67 expression than controls (MMR 3.24, p = 0.028, Figure 2G), whereas baseline Ki-67 expression among all Th cells was comparable (p = 0.547, data not shown). The gene discussed is MKI67; the disease is COVID-19.